Pharma company Boehringer Ingelheim and Click Therapeutics announced an expanded partnership to develop and commercialize another prescription digital therapeutic for patients with schizophrenia. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback